Streetbeat News

Products Services

LLY

NVO

Eli Lilly's CEO announced that the shortage of their weight-loss drug will end 'very soon,' which could positively impact the company's stock. This news may also affect competitors in the weight-loss drug market.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 4:45 pm

AMZN

CRWD

FTNT

GOOG

IBM

MSFT

OKTA

PANW

Stephanie Link from Hightower Advisors highlights key growth trends in the cybersecurity industry, including cloud security, regulatory efforts, and generative AI. Major players like IBM, Palo Alto Networks, Alphabet, CrowdStrike, Microsoft, Amazon, Fortinet, Zscaler, and Okta are poised to benefit from these trends.

Portfolio Pulse from Surbhi Jain

August 01, 2024 | 3:58 pm

DOGEUSD

SHIBUSD

Pepe (CRYPTO: PEPE) has experienced a significant price decline, leading to mixed predictions from prominent crypto traders. While some foresee a further drop, others see a buying opportunity. Despite the decline, a large portion of Pepe holders are still profitable. Pepe's trading volume remains the highest among meme coins.

Portfolio Pulse from Khyathi Dalal

August 01, 2024 | 3:50 pm

CLSK

MARA

RIOT

Bitcoin mining stocks Marathon Digital (MARA) and CleanSpark (CLSK) are experiencing volatility ahead of their earnings reports. Riot Platforms (RIOT) missed analyst estimates, impacting the sector. Marathon Digital is expected to report revenue of $157.84 million and a loss of 14 cents per share, while CleanSpark is expected to report revenue of $110.881 million and a loss of 4 cents per share. CleanSpark also announced new power contracts and a Bitcoin mining site acquisition.

Portfolio Pulse from Adam Eckert

August 01, 2024 | 3:49 pm

XXII

The FDA has issued warning letters to five online retailers for selling unauthorized disposable e-cigarette products. This regulatory action aims to curb the sale of unapproved vaping products.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 3:39 pm

BIIB

Biogen Inc (NASDAQ:BIIB) reported strong Q2 earnings, beating consensus estimates with an adjusted EPS of $5.28 and sales of $2.47 billion. Despite a decline in multiple sclerosis drug sales, the company raised its 2024 profit forecast, expecting new drug launches to offset the decline. The stock is down 1.96% following the report.

Portfolio Pulse from Vandana Singh

August 01, 2024 | 3:23 pm

GLW

LUMN

Lumen Technologies and Corning have announced an agreement that reserves 10% of Corning's global fiber capacity for two years. This deal will more than double Lumen's intercity network miles, enhancing AI capabilities for cloud data centers, enterprises, and public agencies.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 3:06 pm

CHTR

EverPass Media has partnered with Spectrum Business to offer NFL Sunday Ticket and Peacock Sports Pass to bars, restaurants, hotels, and other venues across 41 states. Spectrum Business is EverPass' first official channel partner.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 3:04 pm

GOOG

GOOGL

META

MSFT

Meta Platforms (NASDAQ:META) reported strong Q2 results, surpassing Wall Street estimates with a 22% YoY revenue growth to $39.07 billion and a 73% increase in net income to $13.47 billion. The company also raised its guidance for the current quarter. Meta's ad revenue grew 22%, outperforming Alphabet's 11% growth. Meta is heavily investing in AI infrastructure, with plans to release Llama 4 next year.

Portfolio Pulse from Upwallstreet

August 01, 2024 | 3:02 pm

GNNSF

JNJ

LEGN

Genscript Biotech Corp. (OTC:GNNSF) is considering selling its 48% stake in Legend Biotech (NASDAQ:LEGN) amid potential buyout offers. Legend's core cancer therapy, Carvykti, is expected to peak at $7.3 billion in annual sales. Despite Genscript's strong cash reserves, U.S. policy risks may influence its decision.

Portfolio Pulse from The Bamboo Works

August 01, 2024 | 2:52 pm